These spheroids expressed the prototypic stemness gene CD133 whereas parental GLUC2 spheroids did not (Figure 3J), suggesting that glioma cells dynamically respond to genotoxic therapy by acquiring stem-like morphology and characteristics (47). The gene discussed is PROM1; the disease is glioma.